After a five month stint at biotechnology company Genus as general counsel (GC), Tom Kilroy has returned to banking software company Misys, this time as chief of staff.
Formerly Misys’ GC, Kilroy (pictured) will now be ‘responsible for driving the transformation of the business and developing and executing [its] growth plans’, according to the company’s website and Kilroy’s LinkedIn page.
According to Genus’ website, meanwhile, Baker & McKenzie senior associate Ron Kirschner has been seconded as interim GC. Kirschner joined Bakers in 2012 from Allen & Overy and during his time at Bakers has also been seconded to the in-house M&A team at Barclays Bank.
Kilroy arrives shortly after former Inmarsat chief financial officer (CFO) Rick Medlock joined Misys in January as CFO, prompting speculation, according to the Financial Times, that the group is preparing for an eventual floatation, after Medlock oversaw Inmarsat’s own initial public offering eight years ago.
Kilroy’s re-appointment in a non-legal role comes after he spent a four-month stint as acting chief executive (CEO) at Misys from February 2012, following the departure of former CEO Mike Lawrie. During his short time as stand-in head, Kilroy led the company through its £1.27bn takeover by US private equity house Vista Equity Partners and delisting on 1 June 2012, taking the company private.
He handed over the CEO reins to Bret Bolin and shortly afterwards moved to animal genetics company Genus in July 2013, where he held the role of GC and company secretary.
Simon Dowler was appointed as new group GC, having joined the software group as vice-president in 2008 from BAE Systems.
Kilroy joined Misys in 2009 from GE Healtcare, where he was GC for EMEA. Before that the Farrer & Co trained lawyer was associate GC, bio-sciences, Europe at Amersham.
Neither Misys, Genus or Kilroy were available for comment.